top of page
MEMBERS
Hyeji Kim, M.S Candidate
RESEARCHER
AFFILIATION
National Cancer Center / National Cancer Center Graduate School of Cancer Science and Policy
DEPARTMENT
Targeted Therapy Branch / Cancer Biomedical Science
EDUCATION
• 2014-2020 BS Chonnam National University, Gwangju, Korea
• 2024-present MS candidate National Cancer Center Graduate School of Cancer Science & Policy, Gyeong-gi
CONTACT
PUBLICATIONS
• Kim S, Lee S, Kim H, Kang SJ, Chae H, Kim BJ, Kong J, Kang MC, Kim TM, Kong SY. Delineation of the heterogeneity underlying genomic instability in hereditary breast cancers reveals four disease subtypes. Exp Mol Med. 2026;58(4):1254-1268. doi:10.1038/s12276-026-01693-4. (IF: 8.72; Q1)
• Kim JG, Lee EK, Park SC, Lim MJ, Kim HJ, Yoo KH, Kong SY. Comprehensive review of Peutz–Jeghers syndrome: genetics, clinical manifestations, and management strategies. Lab Med Online. 2025;15(4):277-285.
• Kang MC, Lee S, Kim H, Kang HS, Jung SY, Hwang JA, Kim HJ, et al. PALB2 germline pathogenic variants: frequency, clinical features, and functional analysis of c.3350+5G>A variant in 3987 Korean cancer patients. ESMO Open. 2025;10(3):104132.
• Chun JW, Lee DE, Han N, Heo SB, Kim HJ, Lee MR, et al. Mutant KRAS and GATA6 stratify survival in patients treated with chemotherapy for pancreatic adenocarcinoma: a prospective cohort study. Cancers (Basel). 2025;17(5):896.
• Kang MC, Kong SY, Park SY, Park SY, Lee EG, Yoo CW, Kim HJ, et al. Case report: Extraskeletal Ewing sarcoma with a germline pathogenic variant of SMARCA4. Front Oncol. 2024;14:1422605.
AWARDS
PRESENTATIONS
bottom of page